Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408.SZ) stock: key figures, P/E, revenue and dividend
Consumer Staples · Drug Retail · China · ISIN CNE100005YT4
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 4.53 bn CNY | 5.49 bn CNY |
| Gross profit | 1.48 bn CNY | 1.86 bn CNY |
| Operating income | 256.77 m CNY | 412.96 m CNY |
| EBIT | 237.62 m CNY | 324.61 m CNY |
| Net income | 137.70 m CNY | 191.35 m CNY |
| Diluted EPS – continuing operations | 0.34 CNY | 0.48 CNY |
Full history since 2021, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
Anhui Huaren Health Pharmaceutical Co., Ltd. operates in the medical and healthcare industry. It offers products for oral and throat, nourishing, heat-clearing, respiratory system, and gynecology, as well as provides vitamins and minerals, and detoxifying products. In addition, it provides supplements, and nutrition and health products. Anhui Huaren Health Pharmaceutical Co., Ltd. was founded in 2001 and is based in Hefei, China.
More stocks
- Suning Universal Co Ltd (000718.SZ)
- Advanced Medical Solutions Group PLC (AMS.L)
- Nick Scali Ltd (NCK.AX)
- Summerset Group Holdings Ltd (SNZ.AX)
- Shanghai Allied Industrial Corp. Ltd. A (301419.SZ)
- Jiangsu Favored Nanotechnology Co. Ltd. A (688371.SS)
- Jilin Expressway Co Ltd (601518.SS)
- Shanghai Waigaoqiao Free Trade Zone Group Co Ltd B (900912.SS)
- Xiamen Jiarong Technology Corp. Ltd. (301148.SZ)
- NUSCALE POWER Corp (SMR)
- Bloomin' Brands, Inc. (BLMN)
- Thurgauer Kantonalbank (TKBP.SW)
Not investment advice. All data without warranty, price as of 06.11.2026. Details in the risk notice.